B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Erythropoietin activates Phospholipase C gamma (PLCG)

REACTOME PATHWAY
Reactome: R-HSA-90272772 genes21 compounds

The Erythropoietin activates Phospholipase C gamma (PLCG) pathway (Reactome ID: R-HSA-9027277) involves 2 genes and is affected by 21 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

JAK2LYN

Compounds Affecting Erythropoietin activates Phospholipase C gamma (PLCG)

#CompoundTargets HitStudies
1Dasatinib299
2Azauridine300
3Cladribine297
4Methylene Blue200
52-Methoxyestradiol300
6Astemizole Antihistamine drug now withdrawn from280
7Azathioprine300
8Calcitriol300
9Camptothecin300
10Cytarabine297
11dihydrorotenone13
12Podophyllotoxin14
13streptonigrin299
14Trifluridine295
15Tripterygium300
16Sorafenib300
17tyrphostin ag 14784
18alsterpaullone12
19Crizotinib298
20kenpaullone8
21sp600125117

About the Erythropoietin activates Phospholipase C gamma (PLCG) Pathway

The Erythropoietin activates Phospholipase C gamma (PLCG) pathway is catalogued in Reactome (ID: R-HSA-9027277) and involves 2 genes. In the BiohacksAI corpus, 21 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include JAK2, LYN.